France · Source-listed medicine information

France / CIS 69244971

DOTAREM 0,5 mmol/mL, solution injectable

solution injectable · intraveineuse

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formsolution injectable
Routeintraveineuse
Ingredient entries3
CountryFrance

Product identity

At a glance

Authorisation holder
GUERBET
Authorisation status
Autorisation active
Market status
Commercialisée
Country
France
Source reference
CIS 69244971

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for DOTAREM 0,5 mmol/mL, solution injectable
IngredientStrength / referenceSource role
OXYDE DE GADOLINIUMsolution9,062 g100 ml de solutionSAGroup 1
ACIDE GADOTÉRIQUEsolution27,932 g100 ml de solutionFTGroup 1
DOTAsolution20,246 g100 ml de solutionSAGroup 1

Pack references

Presentations (6)

1 flacon(s) en verre de 60 ml

CIP13 3400930282120

Présentation active · Déclaration de commercialisation
10 flacon(s) en verre de 100 ml

CIP13 3400930282151

Présentation active · Déclaration de commercialisation
1 flacon(s) en verre de 10 ml

CIP13 3400933171346

Présentation active · Déclaration de commercialisation
1 flacon(s) en verre de 15 ml

CIP13 3400933171407

Présentation active · Déclaration de commercialisation
1 flacon(s) en verre de 20 ml

CIP13 3400933171575

Présentation active · Déclaration de commercialisation
1 flacon(s) en verre de 5 ml

CIP13 3400935895424

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 69244971 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source fileRetrievedSource file modified
fr_products.txtNot supplied
fr_composition.txtNot supplied
fr_packs.txtNot supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →